Germany vs SEAR: Estimated antiretroviral therapy coverage among people living with HIV
Germany
91.0%
in 2024
SEAR
22.0%
in 2025
Germany rank
15th
SEAR rank
12th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Germany
- SEAR
How they compare
Germany currently reports 91.0% against 22.0% in SEAR, a difference of 69.0%.
That makes Germany's figure about 4.1 times SEAR's.
Across all 15 years both countries report, Germany has been ahead every year.
Germany ranks 15th and SEAR ranks 12th of 143 countries.
Germany has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Germany | SEAR | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.9% | 12.3% | 66.6% | Germany |
| 2020s | 91.0% | 20.0% | 71.0% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Germany or SEAR?
- Germany, at 91.0% against 22.0% in SEAR as of 2024.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Germany and SEAR?
- 69.0%, with Germany ahead.
- How many years of comparable data are there for Germany and SEAR?
- 15 years are reported by both, from 2010 to 2024.
- How do Germany and SEAR rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Germany ranks 15th and SEAR ranks 12th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.